These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16000891)

  • 21. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio.
    Okumura S; Sakakibara M; Hayashida R; Jinno Y; Tanaka A; Okada K; Hayashi M; Ishii H; Murohara T
    Heart Vessels; 2014 Jan; 29(1):7-14. PubMed ID: 23358876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention.
    Youssef AA; Wu CJ; Hang CL; Cheng CI; Yang CH; Chen CJ; Chen YH; Chai HT; Chua S; Yeh KH; Yip HK
    Circ J; 2006 Dec; 70(12):1538-42. PubMed ID: 17127795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].
    Chen ZQ; Hong L; Wang H; Yin QL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):415-20. PubMed ID: 27323611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.
    Ray KK; Cannon CP
    Curr Opin Lipidol; 2004 Dec; 15(6):637-43. PubMed ID: 15529022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive interventions in myocardial infarction: the role of statin therapy.
    Jones PH; Farmer JA
    Curr Atheroscler Rep; 2008 Apr; 10(2):142-8. PubMed ID: 18417069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention.
    Rodriguez-Granillo GA; Rosales MA; Baum S; Rennes P; Rodriguez-Pagani C; Curotto V; Fernandez-Pereira C; Llaurado C; Risau G; Degrossi E; Doval HC; Rodriguez AE
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1072-81. PubMed ID: 19761985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of acute administration of statins on coronary microcirculation during the pre-revascularization period in patients with myocardial infraction.
    Paraskevaidis IA; Iliodromitis EK; Ikonomidis I; Rallidis L; Hamodraka E; Parissis J; Andoniadis A; Tzortzis S; Anastasiou-Nana M
    Atherosclerosis; 2012 Jul; 223(1):184-9. PubMed ID: 22648087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty.
    Zhao JL; Yang YJ; Pei WD; Sun YH; Chen JL
    Am J Cardiovasc Drugs; 2009; 9(2):81-9. PubMed ID: 19331436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).
    Brener SJ; Mehran R; Brodie BR; Guagliumi G; Witzenbichler B; Cristea E; Xu K; Lansky AJ; Stone GW
    Am J Cardiol; 2011 Oct; 108(7):918-23. PubMed ID: 21764028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
    Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Uyarel H; Ayhan E; Cicek G; Isik T; Ugur M; Bozbay M; Yildirim E; Ergelen M; Eren M
    Coron Artery Dis; 2012 Mar; 23(2):98-104. PubMed ID: 22318130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty.
    Oduncu V; Tanalp AC; Erkol A; Sırma D; Dündar C; Akgün T; Türkyilmaz E; Kılıçgedik A; Gözübüyük G; Tigen K; Izgi A; Kirma C
    Am J Cardiol; 2011 Jan; 107(2):179-85. PubMed ID: 21129710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22.
    Truong QA; Murphy SA; McCabe CH; Armani A; Cannon CP;
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):328-36. PubMed ID: 21487089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.
    Hang CL; Wang CP; Yip HK; Yang CH; Guo GB; Wu CJ; Chen SM
    Chest; 2005 Oct; 128(4):2593-8. PubMed ID: 16236929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.